Kyntra Bio, Inc. (KYNB)
6.31
-0.19
(-2.92%)
USD |
NASDAQ |
Oct 02, 16:00
6.30
-0.01
(-0.16%)
After-Hours: 20:00
Kyntra Bio Max Drawdown (5Y) : 99.63% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.63% |
| August 31, 2026 | 99.63% |
| July 31, 2026 | 99.63% |
| June 30, 2026 | 99.63% |
| May 31, 2026 | 99.63% |
| April 30, 2026 | 99.63% |
| March 31, 2026 | 99.63% |
| February 28, 2026 | 99.63% |
| January 31, 2026 | 99.63% |
| December 31, 2025 | 99.63% |
| November 30, 2025 | 99.63% |
| October 31, 2025 | 99.63% |
| September 30, 2025 | 99.63% |
| August 31, 2025 | 99.63% |
| July 31, 2025 | 99.63% |
| June 30, 2025 | 99.63% |
| May 31, 2025 | 99.55% |
| April 30, 2025 | 99.55% |
| March 31, 2025 | 99.46% |
| February 28, 2025 | 99.46% |
| January 31, 2025 | 99.46% |
| December 31, 2024 | 99.46% |
| November 30, 2024 | 99.46% |
| October 31, 2024 | 99.46% |
| September 30, 2024 | 99.40% |
| Date | Value |
|---|---|
| August 31, 2024 | 99.37% |
| July 31, 2024 | 99.37% |
| June 30, 2024 | 99.37% |
| May 31, 2024 | 99.37% |
| April 30, 2024 | 99.37% |
| March 31, 2024 | 99.37% |
| February 29, 2024 | 99.37% |
| January 31, 2024 | 99.37% |
| December 31, 2023 | 99.37% |
| November 30, 2023 | 99.37% |
| October 31, 2023 | 99.21% |
| September 30, 2023 | 98.72% |
| August 31, 2023 | 98.43% |
| July 31, 2023 | 97.10% |
| June 30, 2023 | 96.30% |
| May 31, 2023 | 88.19% |
| April 30, 2023 | 88.19% |
| March 31, 2023 | 88.19% |
| February 28, 2023 | 88.19% |
| January 31, 2023 | 88.19% |
| December 31, 2022 | 88.19% |
| November 30, 2022 | 88.19% |
| October 31, 2022 | 88.19% |
| September 30, 2022 | 88.19% |
| August 31, 2022 | 88.19% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Vericel Corp. | 73.97% |
| Nektar Therapeutics | 99.39% |
| Capricor Therapeutics, Inc. | 91.80% |
| ARS Pharmaceuticals, Inc. | 95.20% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -66.07 |
| Beta (5Y) | 1.048 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 116.1% |
| Historical Sharpe Ratio (5Y) | -0.4788 |
| Historical Sortino (5Y) | -0.8631 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 47.01% |